Masuyama H - Search Results

1

ADAR1 could be a potential diagnostic target for intrauterine infection patients.

Nakamura K, Shigeyasu K, Vu TH, Maki J, Okamoto K, Masuyama H. Nakamura K, et al. Among authors: masuyama h. Sci Rep. 2024 Nov 27;14(1):29419. doi: 10.1038/s41598-024-81097-4. Sci Rep. 2024. PMID: 39592688 Free PMC article.

2

ADAR1 and AZIN1 RNA editing function as an oncogene and contributes to immortalization in endometrial cancer.

Nakamura K, Shigeyasu K, Okamoto K, Matsuoka H, Masuyama H. Nakamura K, et al. Among authors: masuyama h. Gynecol Oncol. 2022 Aug;166(2):326-333. doi: 10.1016/j.ygyno.2022.05.026. Epub 2022 Jun 11. Gynecol Oncol. 2022. PMID: 35697535

3

ADAR1 has an oncogenic function and can be a prognostic factor in cervical cancer.

Nakamura K, Shigeyasu K, Okamoto K, Matsuoka H, Masuyama H. Nakamura K, et al. Among authors: masuyama h. Sci Rep. 2023 Mar 23;13(1):4720. doi: 10.1038/s41598-023-30452-y. Sci Rep. 2023. PMID: 36959226 Free PMC article.

4

Adenosine Deaminase Family Acting on RNA 1 (ADAR1) May Be a De Novo Target for Endometriosis Treatment.

Vu TH, Nakamura K, Shigeyasu K, Kubo K, Kashino C, Masuyama H. Vu TH, et al. Among authors: masuyama h. In Vivo. 2024 Mar-Apr;38(2):683-690. doi: 10.21873/invivo.13489. In Vivo. 2024. PMID: 38418109 Free PMC article.

5

The adenosine deaminase family acting on RNA 1 can be a useful diagnostic biomarker in chorioamnionitis.

Nakamura K, Shigeyasu K, Maki J, Eto E, Masuyama H. Nakamura K, et al. Among authors: masuyama h. Placenta. 2024 Aug;153:53-58. doi: 10.1016/j.placenta.2024.05.133. Epub 2024 May 23. Placenta. 2024. PMID: 38820942

6

Apolipoprotein-B mRNA-editing complex 3B could be a new potential therapeutic target in endometriosis.

Vu TH, Nakamura K, Shigeyasu K, Kashino C, Okamoto K, Kubo K, Kamada Y, Masuyama H. Vu TH, et al. Among authors: masuyama h. Sci Rep. 2024 Oct 23;14(1):24968. doi: 10.1038/s41598-024-76589-2. Sci Rep. 2024. PMID: 39443671 Free PMC article.

7

Partner relationships, hopelessness, and health status strongly predict maternal well-being: an approach using light gradient boosting machine.

Ooba H, Maki J, Tabuchi T, Masuyama H. Ooba H, et al. Among authors: masuyama h. Sci Rep. 2023 Oct 9;13(1):17032. doi: 10.1038/s41598-023-44410-1. Sci Rep. 2023. PMID: 37813926 Free PMC article.

8

Assessing the efficacy of simulation-based education for paramedics in extended focused assessment with sonography for trauma under physician guidance.

Ohira A, Maki J, Ageta K, Nakato H, Oba H, Mitoma T, Mishima S, Tani K, Kirino S, Eto E, Nakao A, Masuyama H. Ohira A, et al. Among authors: masuyama h. Sci Rep. 2024 Feb 20;14(1):4190. doi: 10.1038/s41598-024-54779-2. Sci Rep. 2024. PMID: 38378769 Free PMC article.

9

Dimethylesculetin ameliorates maternal glucose intolerance and fetal overgrowth in high-fat diet-fed pregnant mice via constitutive androstane receptor.

Masuyama H, Mitsui T, Maki J, Tani K, Nakamura K, Hiramatsu Y. Masuyama H, et al. Mol Cell Biochem. 2016 Aug;419(1-2):185-92. doi: 10.1007/s11010-016-2772-4. Epub 2016 Jul 18. Mol Cell Biochem. 2016. PMID: 27426490

10

Upregulation of Angiogenic Factors via Protein Kinase C and Hypoxia-induced Factor-1α Pathways under High-glucose Conditions in the Placenta.

Mitsui T, Tani K, Maki J, Eguchi T, Tamada S, Eto E, Hayata K, Masuyama H. Mitsui T, et al. Among authors: masuyama h. Acta Med Okayama. 2018 Aug;72(4):359-367. doi: 10.18926/AMO/56171. Acta Med Okayama. 2018. PMID: 30140083 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters